Dimension Therapeutics' P2P Acquisition

Dimension Therapeutics raised a round of funding on November 07, 2017. Investors include Ultragenyx Pharmaceutical.

Dimension Therapeutics is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-…

Articles about Dimension Therapeutics' P2P Acquisition: